Bridge Medicines Revenue and Competitors
Estimated Revenue & Valuation
- Bridge Medicines's estimated annual revenue is currently $402k per year.
- Bridge Medicines's estimated revenue per employee is $100,500
- Bridge Medicines's total funding is $10M.
Employee Data
- Bridge Medicines has 4 Employees.
- Bridge Medicines grew their employee count by 0% last year.
Bridge Medicines's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & director | Reveal Email/Phone |
2 | Advisor & Board Director | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
Bridge Medicines Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.3M | 61 | 7% | N/A | N/A |
#2 | $354.3M | 461 | -2% | $567.1M | N/A |
#3 | $377.1M | 1876 | -1% | N/A | N/A |
#4 | $7.8M | 39 | 8% | N/A | N/A |
#5 | $5.4M | 27 | 0% | N/A | N/A |
#6 | $45M | 224 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -82% | N/A | N/A |
#8 | $9.2M | 46 | 12% | N/A | N/A |
#9 | N/A | 694 | 46% | N/A | N/A |
#10 | $15.5M | 77 | 5% | N/A | N/A |
What Is Bridge Medicines?
Bridge Medicines biotech company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management. Our mission is to move breakthrough research to the patient by bringing the best in modern drug discovery to the service of academic medicine.
keywords:N/A
$10M
Total Funding
4
Number of Employees
$402k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Bridge Medicines News
Sri Lanka says India, World Bank consider $2 billion bridge finance ... of fuel and medicines that have sparked nationwide protests.
Those differences should be understood in the controlled setting of a clinical trial first, not in day-to-day healthcare after the medicine...
... in Royalty-Based Financing Agreement with R-Bridge Healthcare Fund ... development and commercialization of novel medicines for patients...
Bridge Medicines, a NYC-based drug discovery company focused on advancing promising early technologies from concept to clinic, raised additional funding of $10m. The company intends to use the funds to advance its current pipeline of products as well as expand with additional in-licensed techno ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 4 | -33% | N/A |
#2 | $0.3M | 4 | -20% | N/A |
#3 | $0.5M | 4 | 0% | N/A |
#4 | $0.3M | 4 | 0% | N/A |
#5 | $0.3M | 4 | -33% | N/A |